Literature DB >> 11314026

E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.

J Nip1, D K Strom, C M Eischen, J L Cleveland, G P Zambetti, S W Hiebert.   

Abstract

E2F-1 induces p53 accumulation and E2F-1 and p53 form a physical complex, which affects the ability of E2F-1 to activate transcription. We mapped the domains on E2F-1 that interact with p53 and found two p53-binding domains. To understand the functional consequences of the E2F-1/p53 association on p53 activities we identified the domains of E2F-1 that were responsible for the accumulation of p53. Unexpectedly, we found that the E2F-1 transactivation domain was dispensable for p53 induction. By contrast, further deletion of the DP-1 interaction/'marked' box domain eliminated p53 accumulation. Radiolabeling pulse/chase analysis demonstrated that E2F-1 caused post-translational stabilization of p53. Although E2F-1 caused the stabilization of p53, E2F-1 expression impaired p53-dependent transactivation. Thus, the E2F-1 : p53 interaction may provide a checkpoint function to inactivate overactive E2F-1, but the association may also inactivate p53 transactivation to allow cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314026     DOI: 10.1038/sj.onc.1204171

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.

Authors:  Takahito Nakagawa; Masato Takahashi; Toshinori Ozaki; Ken-ichi Watanabe Ki; Satoru Todo; Hiroyuki Mizuguchi; Takao Hayakawa; Akira Nakagawara
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.

Authors:  Harry A Rogoff; Mary T Pickering; Michelle E Debatis; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

3.  A novel E2F-like protein involved in transcriptional activation of cyst wall protein genes in Giardia lamblia.

Authors:  Li-Hsin Su; Yu-Jiao Pan; Yu-Chang Huang; Chao-Cheng Cho; Chia-Wei Chen; Shao-Wei Huang; Sheng-Fung Chuang; Chin-Hung Sun
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

4.  ATM-dependent E2F1 accumulation in the nucleolus is an indicator of ribosomal stress in early response to DNA damage.

Authors:  Ya-Qiong Jin; Guo-Shun An; Ju-Hua Ni; Shu-Yan Li; Hong-Ti Jia
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

5.  Isg15 controls p53 stability and functions.

Authors:  Yi-Fu Huang; Sheena Wee; Jayantha Gunaratne; David P Lane; Dmitry V Bulavin
Journal:  Cell Cycle       Date:  2014-05-20       Impact factor: 4.534

6.  Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

Authors:  Gangjian Qin; Raj Kishore; Christine M Dolan; Marcy Silver; Andrea Wecker; Corinne N Luedemann; Tina Thorne; Allison Hanley; Cynthia Curry; Lindsay Heyd; Deepika Dinesh; Marianne Kearney; Fabio Martelli; Toshinori Murayama; David A Goukassian; Yan Zhu; Douglas W Losordo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-11       Impact factor: 11.205

7.  Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.

Authors:  Jung-Kuang Hsieh; Damian Yap; Daniel J O'Connor; Valentina Fogal; Lynn Fallis; Florence Chan; Shan Zhong; Xin Lu
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 8.  Transcription factors that interact with p53 and Mdm2.

Authors:  Kazushi Inoue; Elizabeth A Fry; Donna P Frazier
Journal:  Int J Cancer       Date:  2015-07-14       Impact factor: 7.396

9.  MEF/ELF4 transactivation by E2F1 is inhibited by p53.

Authors:  Manabu Taura; Mary Ann Suico; Ryosuke Fukuda; Tomoaki Koga; Tsuyoshi Shuto; Takashi Sato; Saori Morino-Koga; Seiji Okada; Hirofumi Kai
Journal:  Nucleic Acids Res       Date:  2010-08-30       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.